Remove 2009 Remove Amortization Remove Business Development Companies
article thumbnail

Is Ares Capital Stock a Buy?

The Motley Fool

Ares Capital is a business development company ( BDC ) that provides financing for middle-market companies (businesses that generate between $10 million and $250 million in earnings before interest, taxes, depreciation, and amortization ( EBITDA ) every year). Image source: Getty Images.

Capital 130
article thumbnail

3 High-Yield Dividend Stocks to Buy Now and Hold for the Next Decade

The Motley Fool

Ares Capital: A 10.05% yield Ares Capital (NASDAQ: ARCC) is a business development company, or BDC. Ares Capital is essentially a lender to midsized companies that have a hard time getting the big banks to return their calls. Ares Capital's dividend hasn't risen in a straight line, but it has increased by 37% since 2009.

Banks 243
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Want to Earn $1,000 in Annual Dividend Income? Invest $11,300 in These 3 High-Yield Stocks

The Motley Fool

Pfizer has raised its dividend payout every year since 2009; at recent prices, it offers a 5.8% Sales of Pfizer's COVID-19 products fell faster than expected but not before the company reinvested heaps of the revenue they generated back into its development pipeline. dividend yield. times their interest expenses.

Investing 130
article thumbnail

Want an Extra $100 in Annual Dividend Income? Invest $1,320 in These 3 High-Yield Stocks

The Motley Fool

At the end of March, the company's net debt level was 2.9 times the adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) it generated over the past 12 months. Although Pfizer's stock price is down, the pharmaceutical company has steadily raised its dividend payout since 2009. dividend yield.

Debt 130